Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Financial Results

Sai Parenterals Financial Results

Sai Parenterals approved audited standalone and consolidated financial results for the year ended March 31, 2026. The board meeting concluded successfully with no other material developments.

Source

BSE filing, NSE: SAIPARENT. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Sai Parenterals Ltd: key numbers

Share price
₹484.05
Market cap
₹2,138 Cr
Revenue (annual)
₹381.0 Cr
Net profit (annual)
₹14.26 Cr
P/E (TTM)
103.0×Sector 46.1×
Promoter holding
51.16%+0.00% QoQ
FII holding
2.85%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Sai Parenterals Ltd

All →
18:36 IST BSE
New Order Win

Sai Parenterals Bags ₹204 Cr Order

Sai Parenterals' subsidiary, Noumed Pharmaceuticals, renewed a 3-year OTC Medicines Supply Agreement with an Australian pharmacy chain, valued at approximately ₹204 Crore.

Value
₹204.0 Cr
Execution
3 years

Other financial results announcements

All →